tips on marketing CBD products without medicinal claims

One of the most prevalent and concerning issues is the use of medicinal claims in marketing. We are all familiar with the potential benefits of cannabinoids, but under UK law, promoting these benefits for a food product is strictly prohibited. Despite this, medicinal claims remain widespread in the sector, as many companies fall back on them to differentiate themselves in a competitive market. However, this is not only risky but legally unsound. Even if a product is genuinely medicinal, licenses must be obtained from the MHRA to legally market or prescribe it. In the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) regulates such products under Part 9, Regulation 165, of the Human Medicines Regulations 2012 (SI 2012/1916). Failure to comply can result in serious repercussions.

We hope this helps guide absolute beginners through the steps to treatment.

Police chiefs, industry executives and transport bosses must work together to keep women and girls safe, the Prime Minster will urge when he convenes leaders in Downing Street later today [Monday 25 N...

Stay updated with insights from the Cannabis Trades Association (CTA) Directors on the UK hemp and cannabis industry. Discover key developments, regulatory updates, market trends, and innovations in the CBD and cannabis sectors.

Your essential resource hub for navigating the cannabis and hemp industry with confidence

Member Directory and information on pricing & tiers, re-joining, benefits, promotions, regulations, T&Cs etc

The CTA announces a new partnership with AcceptCards, one of the UK’s leading payment solution specialists.